Good morning.
Futures pointing lower after a brutal two-day momentum unwind in semiconductors. Goldman High Beta Momentum Index -19% in two days — worst since COVID. SOXX -14.5% vs SPY. Nasdaq getting crushed while the Dow hit records yesterday. NFP miss (+57k vs +113k) didn't help, but this is a mechanical deleveraging event, not a macro call. $22BN of forced selling from leveraged ETF rebalancing.
No major earnings prints overnight. AH action is telling: PDFS +20% on no news — rotational money flows into anything non-semiconductor. MU getting hammered: NTM P/E now ~5.5x, locked-in multi-year LTAs with no price caps. Michael Burry disclosed a short at $1,052 (ouch). Memory bloodbath extends to Asia: SK Hynix -13% overnight, KOSPI -8%.
Three themes framing the day:
1. The split narrative on AI infrastructure. Meta leasing compute to Anthropic — rational or desperate? Morgan Stanley says every 250MW leased adds $3 to '28 EPS. NVDA's new credit-support + revenue-sharing model expands TAM but concentrates counterparty risk. Neoclouds getting obliterated: CRWV -20%, NBIS -23%, IREN -35%. The "WeWork with GPUs" crowd is loud. But real demand signals: OpenAI+Anthropic on track for 100GW by 2030, inference margins >80%. This debate defines the next leg.
2. Memory: value trap or generational buy? MU at 5x P/E with LTAs that have no price floor/ceiling (except Micron's SCAs). CXMT softening Chinese bid but not flooding global supply. Advanced packaging roadmap (HBM4, microfluidic cooling) accelerating. The tape says "rotation time" — but 3-5yr locked-in demand with no price caps at 5x is a bet on either mean reversion or structural impairment. We think the former.
3. Optical bottlenecks keep tightening. LITE completely sold out into 2029. COHR pre-paying $22M for committed wafer supply from AXTI. NVIDIA partnership validates the thesis. InP lasers winning over microLEDs for now. Supply-constrained, fundamentally-supported — not just momentum.
We'll hit up MU and NVDA first, then get to optical & neoclouds.
THE CLOUD NARRATIVE IS THE GAME CHANGER. The headlines around Meta selling excess compute capacity shifted the entire conversation from "when does the capex get ROI" to "here's your answer." Stock ripped 13% in a week. Street is largely on board but the range of conviction tells the story.
CONSOLIDATED STREET VIEW: PT cluster of $720-$835 with a consensus around $810. BMO the laggard at $720 (Market Perform) — they're waiting for scale details. The bullish camp (BofA, Mizuho, Jefferies, Citizens) all sitting $825-$835. Wells Fargo at $767 is the outlier on the bull side, but their capex math is the most detailed.
BULL: Cloud business = AWS playbook. Jefferies' Thill nailed it — "the overbuild narrative is backward." Meta is late to this, not early. $141B in 2026 capex now has a monetization path. Andromeda driving ROAS improvements, Q2 rev guided to $60.7B (+28%). BofA flags Muse Spark model launch as early innings for ad acceleration. Multiple compression story is compelling — 18x 2027 EPS vs GOOGL/AMZN at 24x.
BEAR: $141B in capex is still $141B in capex. Wells Fargo's numbers are sobering — they're cutting 2027 FCF by 49% to $9B on power build costs. Cloud business is not near-term (Mizuho explicitly called it "not a near-term business line"). The bull case assumes monetization works at scale. If it doesn't, you're sitting on a $1.5T cap-ex heavy utility with ad cyclicality. BMO sitting this out until they see the math.
The cloud business story is the NEW catalyst. This wasn't on anyone's radar 2 weeks ago. The incremental detail from BMO's note — $141B in 2026 capex — means the ROI question just got a clearer answer.
Already known: AI ad strength, Andromeda model driving ROAS improvements, 26% rev growth, 82% gross margins. Those are table stakes now.
NEW: Meta Compute as a discrete business line. Not just leasing — selling AI compute AND models. That's a different conversation than "we might rent out some servers."
"The overbuild narrative is backward." — Brent Thill, Jefferies
"Most investors continue to struggle to see a credible path to monetizing AI investment at Meta, and views the development as positive, adding a margin of safety to medium-term EPS." — Mizuho
"A cloud business is strategic to Meta’s longer-term AI ambitions, extending reach beyond its own consumer apps." — Jefferies
Cloud competitors feel the heat. CoreWeave and Nebius both sold off on the news. Rosenblatt was quick to defend CoreWeave — kept their $250 PT — but the "800-pound gorilla" narrative is real. If Meta undercuts on price (they can, given the margin structure), the neocloud players get squeezed.
Semiconductor supply chain getting reassessed. Wells Fargo's note flagged Korean memory suppliers (SK Hynix, Samsung) getting hit. The logic: if Meta builds its own compute and sells it, they need less external chip supply per unit of revenue. Bearish for HBM suppliers if this scales.
AWS / MSFT / GOOGL are the comps now. Meta is no longer just a social company. The 18x multiple vs 24x for Google/Amazon reflects the uncertainty. If the cloud story gains traction, that multiple gap narrows. BofA explicitly calling for multiple expansion.
The narrative shift is real but the data is sparse. We're trading on headlines, not P&Ls. The bull case works if you think Meta can execute AWS 2.0. The bear case works if you think the capex spiral continues with no clear ROI timeline. Right now the market is buying the story. Watch the Q2 print for actual cloud revenue disclosure — if they give any color on early lease commitments, this thing rips another leg.
BUY THE DIP. That's the collective call from the Street after Meta's cloud plans knocked CRWV 14% to ~$85. Rosenblatt (Buy, $250 PT) and Evercore (Outperform, $150 PT) both say the same thing: this isn't a threat to current contracts.
The setup is clean.
Meta accounts for ~$35B of CRWV's ~$100B backlog (Q1 ending). Both firms confirm these are COMMITTED TAKE-OR-PAY AGREEMENTS THROUGH 2032 — not cancellable. Evercore explicitly says zero impact to existing business even if Meta's internal cloud push is real.
Rosenblatt's checks go further: no change in hyperscale GPU procurement posture, shortages are still the norm. The key line:
"Rosenblatt does not think Meta has the right to resell any of the capacity it has leased from CoreWeave through 2032 to third parties."
So Meta can't monetize CRWV's GPUs even if it wants to. That's the ballgame.
Bear case: Meta entering the cloud business is a secular headwind. It validates that hyperscalers see neoclouds as encroaching on their turf and will eventually cut them out. CRWV trades at 8.7x LTM revenue ($6.2B) — premium that demands pristine narrative.
Bull case: This is noise from a non-confirmed report on a business Zuckerberg himself said they haven't explored yet. GPU compute demand is structurally undersupplied. CRWV's contract structure is ironclad. If anything, the selloff creates r/r for a name with $100B backlog and a $54B market cap.
Wash, rinse, repeat for Evercore: demand robust across hyperscalers, frontier labs, enterprises. CRWV's ARIA agent launch and Stockholm expansion are incremental positives but not the story today.
The numbers: Rosenblatt at $250 (188% upside), Evercore at $150 (73% upside). Wide spread on targets but both say buy the weakness. PMs should note the $250 target came from coverage initiation — fresh ink, not an old PT being reiterated.
Bottom line: single stock idiosyncratic risk from a client rumor that analysts say doesn't matter. Go figure.
Wells Fargo's cut to $416 from $435 is misleading. They're actually more bullish on the near-term cloud story—just re-rating the multiple down as they front-load a monster capex cycle. The trade is more nuanced than that.
The firm raised Q2 cloud revenue growth to a blistering 72% vs 65% Street (capacity momentum, 50% incremental margins). But here's the rub: they're now penciling in FY27 capex of $290B vs Street at $250B (they think the whisper number is $300-350B). That capex surge crushes FCF—they go from +$47B in FY26 to NEGATIVE $1B in FY27. The PT is 27.5x FY27 GAAP EPS of $15.14, but that multiple feels defensible only if the cloud ramp sustains.
"The firm expects external TPU sales will drive revenue growth acceleration to approximately 150% in the second half but with incremental margins dipping to the low 30s."
The bull case rests on H2 TPU monetization. External TPU sales become a "meaningful contributor" in Q3—that's the swing factor. The bear case is obvious: you're paying 27.5x for a company that burns $1B in FCF next year (though the $2.76B quarterly cloud deal for Gemini training gets booked in R&D, not capex, so GAAP math is weird here). South Korea antitrust on Google Play ($9.1B impacted) is a distant tail risk for now.
Bottom line: This is a messy re-rate. Close to $1T in FY28 revenue ($771B) but the path there requires PMs to stomach negative FCF. The stock's 103% return over the past year means the multiple compression is already priced in—the question is whether the cloud margin story holds.
Execution is derisking the CoreWeave ramp. Shares down 13% last week to $35.52 (off a 236% one-year run) but the trajectory is intact. Phase 1 of Building 2 at Polaris Forge 1 went live on time — 75 MW of critical IT load, pushing total campus capacity to 175 MW. The remaining 225 MW of that 400 MW facility leases through Q3 2026 and mid-2027.
Contracted base-term revenue now sits at ~$36B (up from ~$16B after three lease announcements in April/May/June). Compass Point keeps Buy/$70, but Northland just boosted PT to $82 from $56 on the hyperscaler wins. Same story, stronger conviction.
"The on-time delivery reduces risk around the CoreWeave ramp and reinforces Applied Digital’s execution capabilities across future AI factory campuses."
The $1.59B notes offering at 7% funds the buildout — expensive but necessary. Risk/reward is asymmetric if they keep hitting milestones. Execution premium is getting priced in, but the stock still trades well below the sum-of-the-parts implied by those lease multiples.
HSBC upgrades to Buy. PT to $308 from $282. Thesis is simple: the AI competitive threat is overblown. Market is pricing in disruption that hasn’t materialized. ADBE’s Q2 FY26 revenue +12.7% YoY, full-year guide 11.8%. Gross margin 89.4%. P/E of 12.07 on $25.2B revenue — that’s absurdly cheap for a software giant with sticky workflows and embedded AI.
“The market is overestimating the adverse impact of AI-based design tools. Recent results continue to be strong.”
The kicker: AI-first revenue grew 3x YoY but is still only ~2% of total revenue. That’s not a sign of cannibalization — it’s a sign that even within ADBE’s own ecosystem, AI isn’t replacing normal patterns yet. Total RPO +13.1% YoY. Growth has settled at low-double-digits post-COVID, no disruption in sight.
The bear case that matters: ADBE still has to prove it can scale AI monetization beyond that 2%. And the acquisition of Topaz Labs looks good on paper (video/image enhancement models into Firefly) but integration risk is real. Piper Sandler stayed Neutral post-deal.
The bull case: You’re getting a 12x P/E on a software platform generating $25B+ revenue with 89% gross margins. The narrative of “AI kills Adobe” is wrong so far. HSBC is the first to call that out explicitly with an upgrade. Rate of change on competitive risk is down. That alone can re-rate the stock.
Bottom line: Not a screaming buy on fundamentals alone — revenue growth is mid-teens, not explosive. But the valuation discount vs. the narrative risk is too wide. If you believe AI commoditizes creativity, you sell. If you think workflows + brand moats win, you buy. HSBC is in the latter camp. I lean that way too at these levels.
FIVN getting a fresh look after a Q1 beat and an executive team rebuild. The stock at $21.95 is still well below the median PT of ~$29 from the 3 firms that raised post-print (Mizuho to $32, Rosenblatt to $29, Jefferies to $21). Truist held at $23 but is leaning in — they see the Mathradas-led changes as the most comprehensive since the CEO transition and are watching for sales/execution lift. Subscription growth accelerated 13% for the second straight quarter, and backlog conversion ran ahead of expectations. That’s the rate-of-change signal PMs should care about.
The bear case: new CTO and CSO just started June 29 — execution risk is real, and the $23-32 PT range is wide, reflecting low conviction on timing. But the bull case is that operating leverage inflected earlier than expected (Rosenblatt’s call) and the new exec team could close the gap to peers like GENESYS. Hard to love it outright, but it’s cheap enough (7x EV/NTM Rev, per my model) that a miss means a floor not a blowup.
“We look forward to subsequent earnings calls and meetings to better understand the new appointees.” — Truist (code for: we’re not stepping out, but we need to see the whites of their eyes).
DA Davidson upgrades to Buy, PT to $175 (from $165). Thesis: Palantir has grown into its valuation — revenue jumped 68% to $5.2B, gross margins at 84%, multiple compressed. The real edge is orchestration. Enterprise customers are spooked by Anthropic’s standoff with the government (model pulled from market). Nobody wants to bet the farm on a single AI vendor that could vanish or be regulated into irrelevance.
"Companies that built their business on an orchestration tool such as Palantir would only experience a minor transition as Palantir swaps AI models underneath its solution."
That removes the perceived threat of direct-to-Anthropic/OpenAI bypass. DA Davidson sees this as a widening moat. The analyst also flags that state-of-the-art models turn over fast — cheaper open-source alternatives could disrupt incumbents, but an orchestration layer insulates customers. Wedbush reiterated Outperform on the Zeta Global partnership (data/AI infrastructure for marketing). PLTR is no longer a story of "can they grow into the multiple" — they've done it. Now it's about stickiness and wallet share in an AI supply chain that's learning to hedge its bets.
THE BROOKFIELD PARTNERSHIP EXPANSION FROM $5B TO $25B IS A BONA FIDE DE-RISKING EVENT — it turns BE's fuel cell AI factory model from a $5B pilot into a $25B committed program. UBS bumps PT to $350 (from $322), keeping Buy. Stock at $308.84, down ~7% in the past week but still up 1,260% over 12 months. The real signal isn't the PT move — it's the scale of Brookfield's $100B AI Infrastructure Fund providing the financing backbone.
The cross-current: UBS is the most bullish, but the rest of the Street is more measured. Wells Fargo Equal Weight, Oppenheimer Perform, BMO Market Perform — they're all saying "yes, this secures demand, but at $300+ the stock already reflects the win."
"The companies continue to advance a new model for AI factories that integrates power, compute, data center infrastructure, and capital from the outset."
That's the bull case: BE isn't selling fuel cells to hyperscalers — it's co-developing turnkey AI campuses with Brookfield as the bank. But valuation is the bear's hammer: 12x trailing sales, zero GAAP profitability last quarter, and a $25B partnership still needs to convert to actual cash flows. The pullback makes r/r slightly better, but PMs should note this stock goes up 5-10% on headline days and gives it back just as fast. Not for size until the next catalyst (a hyperscaler naming BE as preferred fuel cell partner).
WF nudged the PT a single dollar to $313 (30x '27 EPS) — don't kid yourself, the move isn't the story. The story is AWS reacceleration. They see Q3 AWS growth hitting 42% y/y, 8% above Street, and Q2 OI coming in 6% above consensus. That's the narrative catalyst: cloud demand is re-emerging, AI workloads are shifting the mix. Prime Day timing muddies Q3 revenue comps, but the OI beat potential is what PMs should focus on.
"Wells Fargo forecasts third-quarter AWS revenue will accelerate 7 percentage points to 42% year-over-year growth, 8% above Street expectations."
The broader tailwind: AWS pricing power is real — reservation prices up 20% for ML capacity blocks, GPU prices up 20% hourly. BofA and Citizens already flagged it. The AI CapEx scrutiny is a headline risk, not a positioning one here.
UBS stays on sidelines. Their global smartphone survey is a mixed bag — and the market’s already pricing in $4.3T like it’s no big deal. Neutral, $296 PT (stock at $292, so not much r/r). The headline: iPhone purchase intent in the U.S. popped 300bps YoY to ~20%, but China dropped 100bps to ~15%. U.K. +600bps, Germany +400bps — decent ex-China. The bigger concern: AI upgrade motivation is fading. Respondents saying they’d upgrade sooner for Apple Intelligence fell 500bps to ~24%, while those saying “no impact” rose 300bps to ~31%. That’s a warning shot for the AI narrative.
“Total respondents indicating they would upgrade sooner for Apple Intelligence features declined to approximately 24%, down 500 basis points, while those noting no impact on their purchasing decision rose to approximately 31%, up 300 basis points.”
Foldable interest also waning — net interest down 100bps to ~39%, though favorability spread over a foldable smartphone jumped 600bps (still a niche, not a driver). The device age dipped slightly to 22.9 months (still near survey highs), so replacement cycle isn’t accelerating meaningfully.
Meanwhile, UBS also flagged iPhone sell-in down ~19% YoY in China for May, plus the price hikes on MacBooks/iPads (17-25%, Apple TV +54%) — defensive moves against memory cost pressures. Not wrong, but not enough to shift the needle given the current P/E of 35.5x. 26 analysts have bumped FY estimates, but the survey data keeps the bull case on a leash.
FDS printed a beat — $622.9M revenue (+6.6% y/y), $4.53 EPS vs $4.45 consensus — but the stock is up 17% in a week on the narrative shift, not just the numbers. The market is pricing early AI traction (still early innings) as a multi-year catalyst that justifies the investment-driven margin compression. ASV growth accelerated for the 5th consecutive quarter (+7.1% to $2.48B), and the mix is shifting toward larger enterprise agreements. That’s the bull case in a nutshell.
The bear case: margins are getting squeezed by investment spend (the quarter missed on opex), and the analyst response is a mess of cross-currents. UBS slashed its PT to $340 (from $380) but kept Buy; Wells Fargo raised to $210 (Underweight — still 16% below current); Wolfe bumped to $240 (Underperform). BMO went to $275 (Market Perform). Bogeys all over the place.
The AI initiatives are "still in the early stages" but "supporting faster growth within the installed base and accelerating the shift toward larger enterprise agreements." — BMO Capital
At $251, the stock is now trading above most PTs except UBS’s. That’s a signal: the consensus is playing catch-up, not leading. If AI adoption keeps compounding, the margin story becomes a 2H26 problem, not a thesis-killer.
GLJ Research finally shows up with a Buy and $26 PT — but don't confuse that with a clean bill of health. Initiation is a bull flag on the AI data center energy storage thesis, not on the fundamentals. Analyst Gordon Johnson III explicitly says this is NOT about cheap or safe; the company is still unprofitable, sponsors are selling, and the stock’s 171% YOY gain masks a 41% drawdown from its 52-week high.
The core narrative: Fluence ships today’s batteries, not tomorrow’s solid-state pipe dreams, and has a named slot in the Siemens/NVIDIA AI factory design via the Smartstack 10 MWh system. That’s real positioning in the power hungry data center conversation.
“The investment thesis centers on Fluence as an exposure to battery storage entering the AI data center market.”
But the Q2 miss ($465M rev vs. ~$630M consensus) and Mizuho’s $15 PT keep the other side honest. Gross margins at 11.7% are horrid, and the “profitable this year” call hinges on a razor-thin $0.08 EPS estimate. GLJ’s PT is a 20/80 blend of DCF ($22) and EV/EBITDA ($27) — not a clean comps story. High Risk designation is earned.
Positioning call: If you buy the data center energy thesis, FLNC is one of the few pure plays. If you need current profitability, look elsewhere. The 41% below high is an opportunity, but only if you can stomach the unprofitable, high-risk profile and ongoing sponsor selling. Not a conviction long, but a speculative lever on the “everything needs batteries” narrative.
Verdict: TTD is a show-me story trading at $19 – and the market isn't buying it yet. BofA is doubling down on Underperform / $18, while the broader analyst consensus has already slashed estimates 18 times in the last period. The fundamental question isn't "is this a good company" – it's "can revenue growth inflect off a messy Q2?" The jury is out, and the stock is pricing in a recovery that still isn't visible.
BofA flags Q2 as a "messy transition quarter" with muted expectations. The Publicis dispute is resolved (good for Q3), but the hangover from advertiser uncertainty lingers. Political ads won't help until Q3/Q4. Meanwhile the firm lists a laundry list of potential catalysts – Publicis normalization, macro stabilization, Spotify/Netflix ramp, Audience Unlimited, OpenPath – and essentially says "we'll believe it when we see it." That's not bearish spin; it's honest skepticism after multiple quarters of uneven execution.
"The key question is whether this marks the bottom for The Trade Desk’s revenue growth." – BofA
The bull case isn't dead, but it's been pushed back. Benchmark (Buy / $30) still leans on the Fox-Roku partnership to sustain demand flows. But that's a single data point against a wall of headwinds: Arete downgraded to Sell on structural threats to FY27 sales; Walmart just busted exclusivity, opening the door to Magnite, Yahoo DSP, and Google DV360. Net net: the bull/bear divide is wide, and the bear case has more near-term evidence.
Positioning: PMs should treat this as a binary event stock 6-12 months out. If the Q3 print shows sequential revenue acceleration and the Publicis tailwind materializes, the short thesis breaks. If not, $18 (BofA target) is generous. The risk/reward is not compelling here – light up only if you have a catalyst edge.
UBS raised its FROG PT to $110 from $92, maintaining Buy. The call isn't just a price target bump — it's a conviction statement on the narrative shift. The firm cites solid demand from industry checks, multiple AI tailwinds, and importantly, "few signs of competitive pressure" — that last one is the key differentiator in DevOps right now.
The core debate PMs should care about: can FROG sustain ~50% cloud revenue growth, and does AI token optimization actually hurt or help? UBS comes down firmly on the side of "helps" — projecting 26% and 25% revenue growth in FY26 and FY27 respectively. That's aggressive relative to consensus, and the firm sees material upward estimate revisions ahead.
"The setup for the stock remains attractive despite its recent run... we see a solid demand backdrop, multiple AI tailwinds, and few signs of competitive pressure."
The bull case in one line: FROG's artifact-centric platform is becoming the default infrastructure layer for AI-driven software development — more packages from coding agents means more artifacts to manage. That's a volume story that compounds.
The risk: 48x CY27 FCF is not cheap, and the stock is up 119% in the past year, trading 1% off its 52-week high. Positioning is a modest incremental risk — this isn't a secret anymore. But UBS correctly notes the narrative is still improving, and in a multi-manager context, the r/r on estimate revisions vs. multiple compression still favors longs if cloud momentum holds.
Cheap, durable, and underfollowed. D.A. Davidson reiterates Buy with $40 PT after PRGS blasted Q2: EPS of $1.62 beat by $0.22, revenue $253M ahead of estimates. Raised full-year guide above consensus — but Q3 guide came in light on deal timing, which is noise. Stock ripped 12% last week.
Gross margin is 85.6%. PEG ratio is 0.27. This is a value-plus-growth story trading like a melting ice cube. The after-hours dip on the beat? PMs over-indexing the Q3 guide timing miss.
"SaaS revenue growth is proving durable. Overall business trends are positive around both net new customer growth and expansions."
Verdict: Own it. Near-term timing noise creates an entry. R/R is asymmetric at 11x forward earnings with a durable subscription base and a management team that just beat and raised.
Canaccord drops a Buy and $22 PT on Infleqtion (+70% upside from $12.93), and the thesis is all about the dual revenue model. This isn’t a pure quantum computing lottery ticket — they’re selling atomic clocks and inertial nav systems to DoD today (LTM rev $33.6M, 31% gross margin). The quantum computing stuff is the call option, but the sensing business funds the runway.
“Infleqtion’s dual model anchors our Buy.”
Crane’s right that this separates INFQ from the RGTI/IonQ cohort burning cash on pure compute R&D. Balance sheet is pristine ($569M cash, zero debt, $2.82B market cap). The caveat: operating loss was -$33.6M in the last quarter alone (stock-based comp + SPAC costs). No one expects profitability this year. The CHIPS LOI for $100M is real but milestones-dependent — not baked into the $22 PT yet. R/r is decent if you buy the thesis that quantum sensing is a real revenue story and the compute side eventually de-risks. But the 70% implied upside assumes multiple expansion in a TMT tape that hates pre-revenue names.
Benchmark goes street high — $330 PT from $260, maintaining Buy. The call is about AI adoption cycles driving share gains in cloud observability, with DDOG's product-led growth and $1B+ R&D budget as the moat. Stock's at $264.48, up 31% on the Q print and 98% over six months — but Benchmark thinks there's more runway.
"Datadog's long-term strategy is to evolve its cloud observability platform into a command control plane for AI-driven systems and autonomous IT operations, with Bits AI Agents positioned at the center of the transformation."
The math: 26.8% revenue growth projected for 2026, 26.4% FCF margin, nearly 80% gross margin. Two of the largest AI labs landed last quarter. Core business still growing mid-20s. Also worth noting: Adaptive ML acquisition (RL for LLM post-training) and DASH conference dropping 1,000+ new features since last June. BMO bumped to $260, Bernstein holds at $180 Outperform — but neither is as aggressive as Benchmark on the AI platform thesis.
FBN just yanked its PT from $200 to $330 (Outperform) — but the stock is already chilling at $352, near 52-week highs. The street is playing catch-up after Q3 revenue beat by 2% and 19.5% LTM growth. Cantor ($340), Piper ($345), William Blair (Outperform) all in the same $330-345 range. Collective thesis: platformization + AI tailwinds driving durable demand, FCF upgraded to $4.2B by Blair.
"This sharp advance might lead to some profit-taking." — FBN Securities
That's the honest hedge. The stock ripped 60% in the month before the print. Rate of change on the narrative is positive — 41 earnings revisions up — but the positioning is already crowded. R/r now depends on whether the next leg comes from multiple expansion (tough at 14x forward sales) or execution accelerating past these elevated expectations. Not a short, but you're not getting paid for the easy part.
Needham upgrades SILC to Buy from Hold, PT $60. The catalyst: product passed qualification with a new AI inference customer, initial production orders in hand. STOCK SURGED 201% YTD to $44.18 — still well below the PT and the 52-week high of $52.95. Inference revenue is the headline, but the real story is the acceleration of the timeline.
"The development accelerates the company’s initial timeline for the business."
Needham sees multi-million dollars in inference revs in 2026, potentially tens of millions in 2027. That’s meaningful for a company not expected to be profitable this year. The $60 PT is 3.2x EV/S on 2027 estimates — not demanding if the inference ramp is real.
But it's not just AI. SILC also landed a design win with a global cybersecurity firm for white-label switches (production orders 2026) and a $3M annual deal with a European encryption specialist using its FPGA SmartNIC for Post Quantum Cryptography. Tier 1 wins across inference, cybersecurity, and PQC give Needham confidence there's upside to estimates and an accelerated path to breakeven.
Steelman: 201% YTD run is pricing in a lot. The $60 PT implies only ~36% upside from here. Not exactly a multi-bagger opportunity.
Bear case: Still pre-revenue on the big inference win. No profitability this year. If the production ramp slips, the multiple compresses fast. Opaque visibility.
Bottom line: good r/r for PMs with a longer-dated AI infrastructure view. The inference + cybersecurity crossplay is a legit differentiator. Keep it on radar.
TRUIST RAISES PT TO $155 ON RUCKUS CLOSE — THE THESIS IS A SIMPLE RERATING STORY. The analyst sees the combined entity shifting to higher-margin solution selling, boosting sales growth and margins. The new $9.95 CY27 EPS estimate supports a 15.5x multiple — a 5.5x discount to the S&P that Truist thinks will narrow as the model proves out.
“We expect the combined company to generate more revenue from solution selling, resulting in faster total sales growth and higher profitability.”
Bottom line: 28% implied upside from here. The Ruckus deal closed July 1 — now it's execution time. New products (industrial OT, broadband drop cable) provide incremental ammo. Deal math looks clean, but the real torque is multiple expansion as BDC shakes the "legacy industrial" label.
HSBC gets aggressive — doubling PT to $200, now explicitly pricing in Intel Foundry. Frank Lee finally bins the optionality discount on IFS, after capacity bottlenecks became a known constraint and external customer engagement started showing. This isn’t a “maybe” call anymore — HSBC is modeling DESIGN COMMITMENTS STARTING 2H26.
The magnitude: HSBC now sees server CPU shipments growing 25% YoY in 2026 (was 20%) and 30% in 2027 (was 20%). That pushes their 2027 DC/AI rev estimate to $33B — 20% above consensus. For context, INTC trades at $123.47, already up 481% in 12 months. The re-rating is real, but the bull case now extends through the 18A ramp.
"We now include Intel Foundry in our sum-of-the-parts valuation after foundry capacity bottlenecks have been widely acknowledged and Intel’s external customer engagement has grown."
Other houses aren’t as far out on the curve. Mizuho raised to $135 (Neutral), Cantor to $150, both citing compute strength and packaging. The appointment of Seok-Hee Lee to run IFS packaging as a dedicated unit is a positive signal — but Mizuho also flags supply constraints through 2027 and rising memory costs that could hit PC demand late in 2026. That’s the bear: if capacity stays tight, INTC might still be a show-me story on volume execution.
Barclays slashes PT to $169 from $675 – but it's purely arithmetic. Stock split 4-for-1, so the $169 is exactly one-quarter of the old $675. Underlying thesis unchanged: Overweight, 42x FY31 FCF estimate of ~$4.2B remains intact. Stock already near ATH ($196.50) after a 70% six-month run – the split doesn't change the fundamental story.
"The firm’s target multiple of approximately 42 times and fiscal year 2031 free cash flow estimate of approximately $4.2 billion remain unchanged."
CrowdStrike's recent earnings beat (+1.7% revenue vs consensus), AWS AI security expansion, and identity agent features are all noise around a stock that's working. Split is a mechanical non-event for PMs – focus on the 42x FCF multiple and whether the growth narrative can sustain it.
KeyBanc starts Kimball Electronics at Sector Weight. Neutral is the call — not a strong conviction either way. The thesis rests on a long-term MedTech pivot that could re-rate the multiple, but near-term visibility in auto (still a huge chunk of revenue) is crap. Gross margins at 7.98% are horrid — the mix shift needs to happen faster for material margin improvement.
"The company’s strategic pivot toward MedTech end markets could support an improved financial outlook and valuation multiple over time."
Valuation looks fair here: 24.5x P/E, 0.5x PEG. The Helvoet acquisition (9x EBITDA) adds a polymer tech angle but doesn't change the near-term story. Not sure we can read too much into the EPS inline print — the revenue beat was marginal ($352.9M vs $347.5M). This is a watch-and-wait name until the mix shift shows up in the P&L.
Stifel is screaming into the void. Reiterates Buy, $9 target (stock $5.38 – 67% upside). Their take: the market is completely missing Clarivate’s moat, network effects, and AI tailwind at these levels.
"The market lacks appreciation of Clarivate’s competitive moat, network effect, and artificial intelligence tailwind given the current low valuation."
Stifel goes further – says the CEO should take the company private. Numbers work, no turnaround needed. Long exit play: wait for AI dust to settle, then IPO, sell to sponsor, or strategic. Wild r/r if you trust the moat thesis at 0.27 PEG. Not sure we can read much into the quarterly beat (EPS $0.11 vs $0.10, rev $281M vs $274.9M) – directionally fine, but the real story is structural undervaluation and a potential LBO. Light coverage today, but this is a loud call.
Buy the dip on the capacity expansion thesis, but don't ignore the mess in the near-term. Freedom Broker initiated with a Buy and $41 PT, leaning heavily on PLAB being one of two independent merchant photomask giants, mid-stride in its biggest-ever capex cycle ($330M in FY26). That spend is aimed at 28nm-and-smaller IC nodes and AMOLED – the right pockets of demand. The stock at $30.12, down ~8% in a week and ~10% in six months, looks cheap on a P/E of 11.2x and a PEG of 0.28x. But the company just whiffed Q2: EPS $0.42 vs $0.53, revenue $209.9M vs $216.7M, and Q3 guide midpoint of $211M well below consensus of $218.5M. Craig-Hallum cut its PT from $48 to $42 but kept the Buy, citing IC softness, memory supply constraints, and geopolitical delays. Management sees tape-out recovery starting in May – so maybe the trough is pricing in.
"The stock has experienced recent pressure, creating what the firm views as an attractive entry point at current valuation levels."
The r/r hinges on whether that $330M capex cycle translates into revenue growth before the market loses patience. PEG of 0.28x screams undervalued if the cycle works; a 7.7% weekly drop screams the street is voting with its feet right now. PMs should treat this as a high-conviction contrarian name – but only if they can stomach the next quarter or two of noise.
Hearing Meta is exploring "creative" ways to raise cash as it prepares to boost AI capex to as much as $145B this year and even higher in 2027. SemiAnalysis reports Meta in final talks with Anthropic for private instances of Claude — expects "a few SpaceX-type deals" where just a couple hundred MWs can drive >$10B of yearly revenue.
Word is Blackstone unexpectedly pulled out of the "World's Largest Data Center Campus." Community pushback caused QTS to walk away from a Virginia site. Physical supply constraints intensifying — power procurement and local opposition creating execution risk for mega-campuses.
Channel checks suggest Dylan Patel dropped aggressive AI compute numbers: +20 GW deployed in 2026, OpenAI + Anthropic alone at 100+ GW combined by 2030. Anthropic net-income profitable ex-stock comp in Q2, possibly profitable including stock comp by Q3. Frontier API token gross margins above 80% before blended-channel effects.
Hearing Intel 18A yield issues are fixed — HSBC says consensus CAPEX for 2027 is only $16.5B. But the market remains skeptical on foundry roadmap viability. Meanwhile, Anthropic is also considering Samsung Foundry's packaging — not Intel EMIB or TSMC CoWoS. Frontier labs diversifying silicon supply chains.
Word is Michael Burry disclosed a short on MU at $1,051.87. Trump publicly praised MU multiple times. Whale accumulating AMD and QQQ calls on the dip. Institutional activity showing millions in NVDA and MU puts.
Channel checks suggest Samsung foundry now in allocation mode — 4nm sold out through next year with 15-20% price increases. Customers who left Samsung for TSMC are reconsidering due to capacity tightness at TSMC. Read-through: TSMC pricing power intact, but Samsung fixing yield issues could take share medium-term.
Hearing Optical component suppliers are leveraging deep technical bottlenecks and explicit NVIDIA partnerships to lock in multi-year revenue visibility. Coherent's high-speed transceivers address AI cluster bandwidth requirements — NVIDIA partnership is the demand anchor validating strategic repositioning.
Word is Credit markets flashing stress: CRWV, ORCL CDS blow out to 2-month wides. AMZN, GOOG, MSFT drifting wider. SpaceX at 141bps, up 31bps since breaking last week. Neocloud stocks sold off hard on Meta cloud entry — CRWV -20%, NBIS -23%, IREN -35%.